MWS
ARQT icon

MFA Wealth Services’s Arcutis Biotherapeutics ARQT Stock Holding History

MFA Wealth Services’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$428K Hold
16,196
– – 0.25% 88
2026
Q2 		$425K Hold
16,196
– – 0.25% 92
2026
Q1 		$382K Buy
+16,196
New +$413K 0.25% 92

Other funds holding ARQT

Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

MFA Wealth Services's ARQT Position: Q3 2026 in Review

MFA Wealth Services held its Arcutis Biotherapeutics (ARQT) position steady in Q3 2026 at 16,196 shares worth $428K. The position accounts for 0.25% of the portfolio, ranked #88.

MFA Wealth Services first reported a position in ARQT in Q1 2026 and has held it in 3 quarters since. 30 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • MFA Wealth Services held 16,196 shares of Arcutis Biotherapeutics worth $428K as of Q3 2026.
  • MFA Wealth Services left its Arcutis Biotherapeutics share count unchanged in Q3 2026.
  • Arcutis Biotherapeutics made up 0.25% of MFA Wealth Services's portfolio in Q3 2026, its #88 holding.
  • MFA Wealth Services first reported a position in Arcutis Biotherapeutics in Q1 2026 and has held it in 3 quarters since.
  • 30 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on MFA Wealth Services's 13F filing for Q3 2026, filed 14 Oct 2026.